We recently observed that Treg resistance of freshly isolated MS T cells ex vivo was associated with an accelerated IL-6 production [4,5] and that blockade of IL-6 signaling restored MS T cells responsiveness (Figure 3B). The gene discussed is IL6; the disease is myeloid sarcoma.